Cancer-associated venous thromboembolism
2022 · Nature Reviews Disease Primers · 392 citations
https://doi.org/10.1038/s41572-022-00336-y
F
Florian Moik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
3.3K
Citations
25
h-index
40
i10-index
Florian Moik is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Inflammatory Biomarkers in Disease Prognosis & Chemotherapy-induced cardiotoxicity and mitigation. The author has an h-index of 25, co-authored 91 publications.
ORCID: 0000-0001-7738-4119Papers by this author
worksGemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
2021 · European Journal of Cancer · 54 citations
https://doi.org/10.1016/j.ejca.2021.03.040
Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer
2022 · Journal of Thrombosis and Haemostasis · 53 citations
https://doi.org/10.1111/jth.15880
Molecular diagnostics tailoring personalized cancer therapy—an oncologist’s view
2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 35 citations
https://doi.org/10.1007/s00428-023-03702-7
Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer
2020 · Thrombosis Research · 32 citations
https://doi.org/10.1016/j.thromres.2020.01.002
Atrial fibrillation and cancer: prevalence and relative risk from a nationwide study
2023 · Research and Practice in Thrombosis and Haemostasis · 23 citations
https://doi.org/10.1016/j.rpth.2022.100026
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat